Biblioteca Setorial Tereza Brasileiro Silva UFCG,
Background: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured…
Background: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured…
Just published: Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients…